Building Robust, Patient-centric Control Strategies Integrated Quality and Control for ATMPs
Cell and gene therapies (CGTs) have transformed what is possible for patients, but they bring a new level of complexity and demand new approaches in manufacturing, quality, and control strategies. This panel will explore industry challenges and risks, and discuss approaches to reliably deliver CGTs to patients.
Panelists will cover topics including Quality by Design, contamination control, and manufacturing network strategies to drive success. Join us for an engaging evening, learn from the expertise of the panelists, and gain tools to get ahead in an evolving industry.
This event is hosted by ISPE Women in Pharma and the ATMP Community of Practice. Networking will follow the panel.
Panelists
- Mia Hanson | Manager, Quality Assurance Sterility Assurance at BMS
- Mary Rodley | Independent Consultant, C> Technical and Strategy Services
- Adam Hughes | Former Associate Director, MSAT Cell Therapy Operations at BMS
Date and time
Location
Agenda
- Panel Session: 5:00 PM to 6:00 PM
- Networking: 6:00 PM to 7:30 PM (food and drinks provided)
Price
- Member: $25
- Non-Member: $35
- Event Sponsor: $500
Drinks and food provided.